Ddavp and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ddavp (desmopressin acetate) and Loraz (lorazepam). Common drug interactions include abdominal pain among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Ddavp and Loraz. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Ddavp?

Ddavp has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 2,614 Ddavp users. Check the latest studies of Ddavp.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.



On Jul, 12, 2026

35 people who take Ddavp and Loraz together, and have interactions are studied.

Ddavp and Loraz drug interactions.

What are the common drug interactions of Ddavp and Loraz, by gender? *:

female:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Urinary tract infection
  4. Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
  5. Confusional state
  6. Cystitis (inflammation of the wall of the bladder)
  7. Diarrhoea
  8. Dysstasia (difficulty in standing)
  9. Hospitalisation
  10. Hyperglycaemia (high blood sugar)

male:

  1. Diarrhoea
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. Pyrexia (fever)
  4. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Eye disorder
  7. Pharyngeal disorder
  8. Rash
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Vomiting

What are the common drug interactions of Ddavp and Loraz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. White blood cell count increased
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. White blood cell count decreased
  4. Hypertension (high blood pressure)
  5. Abdominal pain lower
  6. Aggression
  7. Atelectasis (partial or complete collapse of the lung)
  8. Back pain
  9. Blood creatine phosphokinase increased
  10. Body temperature increased

20-29:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. White blood cell count decreased

30-39:

n/a

40-49:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Extranodal marginal zone b-cell lymphoma (malt type) (cancer originating from b cells in the marginal zone of the malt)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Fungal infection
  5. Gastric ulcer (stomach ulcer)
  6. Hyperglycaemia (high blood sugar)
  7. Hypertriglyceridaemia (excess of triglycerides in the blood)
  8. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  9. Infection
  10. Influenza like illness

50-59:

  1. Confusional state
  2. Hyperglycaemia (high blood sugar)
  3. Hyperosmolar state (life-threatening emergency manifested by marked elevation of blood glucose)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Drug ineffective
  6. Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
  7. Death

60+:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. Pyrexia (fever)
  4. Acute myocardial infarction (acute heart attack)
  5. Bipolar disorder (mood disorder)
  6. Blood creatine phosphokinase increased
  7. Blood glucose decreased
  8. Blood glucose increased
  9. Cystitis (inflammation of the wall of the bladder)
  10. Deafness

What are the existing conditions these people have? *

  1. Pain: 8 people, 22.86%
  2. Agitation (state of anxiety or nervous excitement): 6 people, 17.14%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 11.43%
  4. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 4 people, 11.43%
  5. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 11.43%
  6. Multiple Allergies (allergy to multiple agents): 3 people, 8.57%
  7. Bedwetting: 3 people, 8.57%
  8. Lactose Intolerance (inability to digest lactose): 3 people, 8.57%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 8.57%
  10. Depression: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Ddavp and Loraz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ddavp and Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ddavp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ddavp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate and lorazepam (the active ingredients of Ddavp and Loraz, respectively), and Ddavp and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: